Giselle Amanda Borges E Soares

Ms. Giselle Amanda Borges E Soares

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 January 2022 in Materials
Verified
Journal Article
Open access
PDF file
Tanima BhattacharyaTanima Bhattacharya
Tanima Bhattacharya
GSGiselle Amanda Borges E Soares
Giselle Amanda Borges E Soares
HCHITESH CHOPRA
HITESH CHOPRA
MRMd. Mominur Rahman
Md. Mominur Rahman
Ziaul HasanZiaul Hasan
Ziaul Hasan
SIMONA CAVALUSIMONA CAVALU
SIMONA CAVALU
The strategies involved in the development of therapeutics for neurodegenerative disorders are very complex and challenging due to the existence of the blood-brain barrier (BBB), a closely spaced network of blood vessels and endothelial cells that functions to prevent the entry of unwanted substances in the brain. The emergence and advancement of nanotechnology shows favourable prospects to overcome this phenomenon. Engineered nanoparticles conjugated with drug moieties and imaging agents that have dimensions between 1 and 100 nm could potentially be used to ensure enhanced efficacy, cellular uptake, specific transport, and delivery of specific molecules to the brain, owing to their modified physico-chemical features. The conjugates of nanoparticles and medicinal plants, or their components known as nano phytomedicine, have been gaining significance lately in the development of novel neuro-therapeutics owing to their natural abundance, promising targeted delivery to the brain, and lesser potential to show adverse effects. In the present review, the promising application, and recent trends of combined nanotechnology and phytomedicine for the treatment of neurological disorders (ND) as compared to conventional therapies, have been addressed. Nanotechnology-based efforts performed in bioinformatics for early diagnosis as well as futuristic precision medicine in ND have also been discussed in the context of computational approach.

22 December 2021 in Plants
Verified
Journal Article
Open access
PDF file
GSGiselle Amanda Borges E Soares
Giselle Amanda Borges E Soares
Tanima BhattacharyaTanima Bhattacharya
Tanima Bhattacharya
TCTulika Chakrabarti
Tulika Chakrabarti
PTPriti Tagde
Priti Tagde
SIMONA CAVALUSIMONA CAVALU
SIMONA CAVALU
Essential oils (EOs) have been traditionally used as ancient remedies to treat many health disorders due to their enormous biological activities. As mainstream allopathic medication currently used for CNS disorders is associated with adverse effects, the search to obtain safer alternatives as compared to the currently marketed therapies is of tremendous significance. Research conducted suggests that concurrent utilization of allopathic medicines and EOs is synergistically beneficial. Due to their inability to show untoward effects, various scientists have tried to elucidate the pharmacological mechanisms by which these oils exert beneficial effects on the CNS. In this regard, our review aims to improve the understanding of EOs’ biological activity on the CNS and to highlight the significance of the utilization of EOs in neuronal disorders, thereby improving patient acceptability of EOs as therapeutic agents. Through data compilation from library searches and electronic databases such as PubMed, Google Scholar, etc., recent preclinical and clinical data, routes of administration, and the required or maximal dosage for the observation of beneficial effects are addressed. We have also highlighted the challenges that require attention for further improving patient compliance, research gaps, and the development of EO-based nanomedicine for targeted therapy and pharmacotherapy.

21 February 2022 in Processes
Verified
Journal Article
Open access
PDF file
Tanima BhattacharyaTanima Bhattacharya
Tanima Bhattacharya
DDDebashrita Das
Debashrita Das
GSGiselle Amanda Borges E Soares
Giselle Amanda Borges E Soares
PCPrasun Chakrabarti
Prasun Chakrabarti
ZAZhaoquan Ai
Zhaoquan Ai
SIMONA CAVALUSIMONA CAVALU
SIMONA CAVALU
The difficulty of achieving targeted drug delivery following administration of currently marketed anticancer therapeutics is a still a concern. Metallic nanoparticles (NPs) developed through nanotechnology breakthroughs appear to be promising in this regard. Research studies pertaining to gold NPs have indicated their promising applicability in cancer diagnosis, drug delivery and therapy. These NPs have also recently paved the path for precise drug delivery and site-specific targeting. Our review paper thus highlights the scope and impact of biogenetically generated gold nanoparticles (NPs) in cancer therapy. In a critical, constructive, and methodical manner, we compare the advantages offered by gold NPs over other metal NPs. Moreover, we also focus on novel ‘greener’ strategies that have been recently explored for the preparation of gold NPs and shed light on the disadvantages of conventional NP synthesis routes. Future prospects pertaining to the use of gold NPs in oncotherapy and domains that require further investigation are also addressed.

8 July 2024
Verified
Preprint
Open access
PDF file
GSGiselle Amanda Borges E Soares
Giselle Amanda Borges E Soares
I do like how the abstract is worded. However, the scientific backing in the paper is lacking. I would prefer to have some studies on Valproate mentioned in the paper along with the findings. A table with dosages, routes of administration tested, spe...

8 July 2024
Verified
Preprint
Open access
PDF file
GSGiselle Amanda Borges E Soares
Giselle Amanda Borges E Soares
In its current state, the manuscript is not fit for publication. The following points need to be addressed: * The title is too complex and needs simplification. * Abstract contains a spelling error (Occimum instead of Ocimum) * There are several...